Tea and coffee drinking and ovarian cancer risk: results from the Netherlands Cohort Study and a meta-analysis

被引:44
作者
Steevens, J.
Schouten, L. J.
Verhage, B. A. J.
Goldbohm, R. A.
van den Brandt, P. A.
机构
[1] Maastricht Univ, Dept Epidemiol, NL-6200 MD Maastricht, Netherlands
[2] TNO Qual Life, Leiden, Netherlands
关键词
tea; coffee; ovarian neoplasms; meta-analysis; aetiology; cohort studies;
D O I
10.1038/sj.bjc.6604008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In a cohort study, ovarian cancer (280 cases) showed no significant association with tea or coffee, the multivariable rate ratios being 0.94 (95% confidence interval (CI): 0.89, 1.00) and 1.04 (95% CI: 0.97, 1.12) per cup per day, respectively. A meta-analysis also produced no significant findings overall, though the cohort studies showed a significant inverse association for tea.
引用
收藏
页码:1291 / 1294
页数:4
相关论文
共 50 条
  • [21] Alcohol and ovarian cancer risk: results from the Netherlands Cohort Study
    Leo J. Schouten
    Maurice P.A. Zeegers
    R. Alexandra Goldbohm
    Piet A. van den Brandt
    Cancer Causes & Control, 2004, 15 : 201 - 209
  • [22] Alcohol and ovarian cancer risk: results from the Netherlands Cohort Study
    Schouten, LJ
    Zeegers, MPA
    Goldbohm, RA
    van den Brandt, PA
    CANCER CAUSES & CONTROL, 2004, 15 (02) : 201 - 209
  • [23] A meta-analysis of coffee and tea consumption and the risk of glioma in adults
    Malerba, Stefano
    Galeone, Carlotta
    Pelucchi, Claudio
    Turati, Federica
    Hashibe, Mia
    La Vecchia, Carlo
    Tavani, Alessandra
    CANCER CAUSES & CONTROL, 2013, 24 (02) : 267 - 276
  • [24] Association between tea and coffee consumption and brain cancer risk: an updated meta-analysis
    Song, Yang
    Wang, Zhiyun
    Jin, Yanyu
    Guo, Jie
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2019, 17 (1)
  • [25] Association between tea and coffee consumption and brain cancer risk: an updated meta-analysis
    Yang Song
    Zhiyun Wang
    Yanyu Jin
    Jie Guo
    World Journal of Surgical Oncology, 17
  • [26] Total, caffeinated and decaffeinated coffee and tea intake and gastric cancer risk: Results from the EPIC cohort study
    Sanikini, Harinakshi
    Dik, Vincent K.
    Siersema, Peter D.
    Bhoo-Pathy, Nirmala
    Uiterwaal, Cuno S. P. M.
    Peeters, Petra H. M.
    Alez, Carlos A. Gonz
    Zamora-Ros, Raul
    Overvad, Kim
    Nneland, Anne Tj
    Roswall, Nina
    Boutron-Ruault, Marie-Christine
    Fagherazzi, Guy
    Racine, Antoine
    Kuehn, Tilman
    Katzke, Verena
    Boeing, Heiner
    Trichopoulou, Antonia
    Trichopoulos, Dimitrios
    Lagiou, Pagona
    Palli, Domenico
    Grioni, Sara
    Vineis, Paolo
    Tumino, Rosario
    Panico, Salvatore
    Weiderpass, Elisabete
    Skeie, Guri
    Braaten, Tonje
    Huerta, Jose Maria
    Sanchez-Cantalejo, Emilio
    Barricarte, Aurelio
    Sonestedt, Emily
    Wallstrom, Peter
    Nilsson, Lena Maria
    Johansson, Ingegerd
    Bradbury, Kathryn E.
    Khaw, Kay-Tee
    Wareham, Nick
    Huybrechts, Inge
    Freisling, Heinz
    Cross, Amanda J.
    Riboli, Elio
    Bueno-de-Mesquita, H. B
    INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (06) : E720 - E730
  • [27] Coffee consumption and pancreatic cancer risk: An update meta-analysis of cohort studies
    Ran, Heng-Quan
    Wang, Jun-Zhou
    Sun, Chang-Qin
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2016, 32 (01) : 253 - 259
  • [28] Coffee consumption and the risk of gastric cancer: a meta-analysis of prospective cohort studies
    Li, Liqing
    Gan, Yong
    Wu, Chunmei
    Qu, Xianguo
    Sun, Gang
    Lu, Zuxun
    BMC CANCER, 2015, 15
  • [29] Association between tea drinking and endometrial cancer risk: a meta-analysis
    Gao, Yu
    Cao, Zhihong
    Zhou, Fushun
    Zhao, Yanmei
    Tang, Lihong
    Zhang, Hongjuan
    FOOD SCIENCE AND TECHNOLOGY, 2022, 42
  • [30] Are coffee and tea consumption associated with urinary tract cancer risk? A systematic review and meta-analysis
    Zeegers, MPA
    Tan, FES
    Goldbohm, RA
    van den Brandt, PA
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2001, 30 (02) : 353 - 362